The Short Answer

Yes, liver surgery can be performed on a patient with cirrhosis — but candidacy is narrow. In China, the liver surgery with cirrhosis cost China ranges from $18,000 to $45,000, which is roughly one-third to one-fifth of what the same procedure costs in the United States. That price gap gets attention. But the real question is not whether the surgery is cheaper. It is whether your remaining liver function can sustain you through the operation and the weeks after. A patient with compensated cirrhosis and a small, well-placed tumor may be an excellent candidate. A patient with decompensated cirrhosis, ascites, or portal hypertension faces risks that no surgeon — in Shanghai or Houston — can erase.

Our team does not perform surgery. We are not a hospital. What we do is connect you with hepatobiliary surgical teams at China’s top-tier centers who evaluate your specific liver function, tumor characteristics, and overall physiology before anyone books an operating room. That evaluation is everything.

Who This Is Right For — and Who It Isn’t

Cirrhosis is not one disease. It is a scarred liver, and the degree of scarring changes the surgical calculus completely. The Child-Pugh score — a clinical tool that grades liver function from A to C — draws the line most surgeons use.

A patient who typically qualifies:

• Child-Pugh Class A cirrhosis (well-compensated liver function)
• A solitary tumor under 5 cm, or up to three tumors each under 3 cm, with no major vascular invasion
• Platelet count above 100,000 and no clinically significant ascites
• No evidence of hepatic encephalopathy
• Performance status that allows independent daily living

A patient who should not pursue liver resection:

• Child-Pugh Class C cirrhosis (decompensated, high surgical mortality)
• Severe portal hypertension with a hepatic venous pressure gradient above 10 mmHg
• Active ascites requiring diuretics or paracentesis
• Multiple tumors spread across both lobes of the liver
• Significant cardiac or pulmonary comorbidities that compound surgical risk

Being honest about who should stay home is not discouragement. It is protection. A patient with decompensated cirrhosis who flies to China hoping for a miracle resection will likely be told the same thing by every reputable surgical team: the risk of postoperative liver failure is too high. That patient would be better served exploring ablation, transarterial chemoembolization, or transplantation evaluation in their home country.

The Options, Compared

When a cirrhotic liver also harbors a tumor, the treatment menu is not long. Three genuine options dominate, and the choice hinges on liver reserve, tumor anatomy, and what the patient is willing to endure. Here is how they stack up.

Resection offers the best chance at a cure for a single tumor — but only if the liver can take the hit. Ablation trades some curative potential for a much gentler physiological toll. A patient with borderline liver function who insists on resection is making a gamble. A patient with good function who chooses ablation for a 4 cm tumor is likely undertreating. The right column is not obvious until imaging and liver function tests are reviewed by a hepatobiliary surgeon who does this weekly.

How Liver Surgery Is Performed on a Compromised Liver

The question “how is liver surgery performed on compromised liver” gets to the core anxiety. A healthy liver regenerates. A cirrhotic liver regenerates poorly, if at all. Remove too much, and the patient dies of liver failure — not cancer. So the surgical strategy in China’s top hepatobiliary centers revolves around one metric: the future liver remnant, or FLR.

Before surgery, the team calculates exactly how much functioning liver will remain after the planned resection. For a healthy liver, 20-25% FLR is acceptable. For a cirrhotic liver, surgeons typically demand at least 40% FLR — and often more, depending on the degree of fibrosis seen on elastography or biopsy. If the FLR is insufficient, the surgery is not simply canceled. There is a bridge technique: portal vein embolization. The portal branch feeding the tumor-bearing segment is blocked, diverting blood flow to the healthy side. Over 3 to 6 weeks, the healthy lobe hypertrophies. Then the resection proceeds.

Intraoperatively, the surgical team uses intraoperative ultrasound to map the tumor’s relationship to major vessels. Inflow occlusion — the Pringle maneuver — is used sparingly in cirrhotic livers because the remnant tolerates ischemia poorly. Some centers use laparoscopic approaches for peripheral tumors, which reduces ascites formation and wound complications. But the core principle does not change: preserve every viable hepatocyte possible. The surgery is less about what you take out and more about what you leave behind.

What It Costs

The liver surgery with cirrhosis cost China breaks down into components that vary by hospital tier, surgical complexity, and length of stay. Here is what patients typically encounter.

An open anatomical liver resection at a top-tier public hospital’s international department — Zhongshan Hospital affiliated with Fudan University in Shanghai, for example — runs from $22,000 to $45,000. This includes the surgeon’s fee, anesthesia, operating room charges, standard inpatient stay of 10 to 14 days, nursing care, and basic postoperative imaging. It does not include pre-surgical portal vein embolization if needed, which adds $5,000 to $8,000. It also does not include the cost of extended ICU stay if postoperative complications arise.

A laparoscopic minor resection at the same tier of hospital typically falls between $15,000 and $28,000, with a shorter stay of 4 to 7 days. Private international hospitals in Shanghai and Beijing — facilities with JCI accreditation and English-speaking staff — charge $35,000 to $70,000 for the same procedures, but offer direct insurance billing and a care environment closer to what Western patients expect.

Ablation procedures are substantially less: $6,000 to $15,000, often performed percutaneously with a 1 to 2 night observation stay. The variance across all these numbers comes from tumor location, the need for intraoperative blood products, and whether the patient requires preoperative optimization like embolization or nutritional support.

Practical Considerations: Records, Visas, and the Path Home

Arriving in China for liver surgery is not like booking a hotel. The logistical chain matters, and missing one link can delay everything.

Medical records. Before any surgical team evaluates you, they need a complete package: recent triphasic liver CT or MRI with contrast (DICOM format preferred), liver function tests including albumin, bilirubin, INR, and platelet count, viral hepatitis serologies, and any prior biopsy or elastography results. If you have had previous ablations, resections, or TACE procedures, those operative and imaging records are essential. Our team handles certified translation of these documents into Chinese — a step that, if skipped, means the surgeon literally cannot read your history.

Visa. Foreign nationals traveling to China for medical treatment apply for an S2 visa, with the purpose noted as private affairs including medical treatment. The application requires an invitation letter from the treating hospital, which we coordinate after a treatment plan is confirmed. Accompanying family members also apply under the S2 category. Processing times vary by embassy, but 2 to 4 weeks is typical. Do not book flights until the visa is in hand.

Payment. Public hospitals in China require upfront payment — a deposit at admission, with settlement at discharge. International insurance plans are typically reimbursed after the fact, not directly billed at public facilities. Private international hospitals can often bill insurers directly. We advise patients to confirm coverage for overseas liver surgery with their insurer before committing to travel.

Follow-up after returning home. A patient who undergoes liver resection in China needs a clear handoff plan. The surgical team will provide a discharge summary, operative note, pathology report, and a recommended surveillance schedule — typically CT or MRI every 3 to 6 months for the first two years. You need a hepatologist or oncologist in your home country willing to receive these records and continue the monitoring. We help compile and translate the full discharge package, but the ongoing relationship with your home physician is yours to maintain.

Frequently Asked Questions